Novel mutation in an Egyptian patient with infantile Canavan disease.
Author | Zaki, Osama K |
Author | El Abd, Heba S |
Author | Mohamed, Shaimaa A |
Author | Zayed, Hatem |
Available date | 2018-02-08T11:27:29Z |
Publication Date | 2016-06-01 |
Publication Name | Metabolic Brain Disease |
Identifier | http://dx.doi.org/10.1007/s11011-015-9772-z |
Citation | Zaki, O.K., El Abd, H.S., Mohamed, S.A. et al. Metab Brain Dis (2016) 31: 573. https://doi.org/10.1007/s11011-015-9772-z |
ISSN | 0885-7490 |
Abstract | Canavan disease (CD) is a rare fatal childhood neurological autosomal recessive genetic disease caused by mutations in the ASPA gene, which lead to catalytic deficiency of the ASPA enzyme that catalyzes the deacetylation of NAA. It is a severe progressive leukodystrophy characterized by spongiform degeneration of the white matter of the brain. CD occurs frequently among Ashkenazi Jewish population, however it has been reported in many other ethnic groups with significantly lower frequency. Here, we report on a 2 year-old Egyptian child with severe CD who harbors a novel homozygous missense variant (c.91G > T, p.V31F) in the ASPA gene. The clinical, radiological, and molecular genetic profiles are reviewed in details. |
Language | en |
Publisher | Springer Verlag (Germany) |
Subject | Aspartoacylase Canavan disease MRI MRS N-acetyl-aspartate |
Type | Article |
Pagination | 573–577 |
Issue Number | 3 |
Volume Number | 31 |
ESSN | 1573-7365 |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |
This item appears in the following Collection(s)
-
Biomedical Sciences [739 items ]